Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to 684.54%.

  • Firefly Neuroscience's EBIT Margin rose 122488000.0% to 684.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 1450.52%, marking a year-over-year increase of 96102900.0%. This contributed to the annual value of 618.07% for FY2023, which is 5689100.0% down from last year.
  • Per Firefly Neuroscience's latest filing, its EBIT Margin stood at 684.54% for Q3 2025, which was up 122488000.0% from 546.49% recorded in Q2 2025.
  • Firefly Neuroscience's 5-year EBIT Margin high stood at 6247.27% for Q4 2024, and its period low was 12933.33% during Q3 2024.
  • Moreover, its 5-year median value for EBIT Margin was 55.99% (2022), whereas its average is 2409.7%.
  • Over the last 5 years, Firefly Neuroscience's EBIT Margin had its largest YoY gain of 144946400bps in 2024, and its largest YoY loss of -126143600bps in 2024.
  • Over the past 5 years, Firefly Neuroscience's EBIT Margin (Quarter) stood at 110.99% in 2021, then skyrocketed by 54bps to 51.38% in 2022, then plummeted by -15951bps to 8247.37% in 2023, then soared by 176bps to 6247.27% in 2024, then plummeted by -111bps to 684.54% in 2025.
  • Its last three reported values are 684.54% in Q3 2025, 546.49% for Q2 2025, and 4802.33% during Q1 2025.